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HIV and STI risk reduction through physician training 
UNAIDS has set ambitious targets to end the epidemic 
of HIV/AIDS by 2030 through the 90-90-90 strategy—
ie, 90% of HIV infected individuals diagnosed, 90% 
diagnosed being treated, and 90% treated achieving 
viral suppression.1 Physicians will contribute immensely 
to the achievement of each of these targets. In a 
randomised controlled trial (the Ai Shi Zi study) in 
The Lancet Global Health, Don Operario and colleagues2 
have shown the potentially pivotal role of physicians 
in treatment and prevention of sexually transmitted 
infections (STIs) in China. In the study, physicians 
were trained in HIV and STI knowledge, treatment, 
and risk reduction counselling, and were motivated to 
integrate prevention and treatment into routine care. 
Patients of the physicians who were randomly assigned 
to training experienced 38% lower odds of combined 
gonorrhoea and chlamydia reinfection and 32% lower 
odds of gonorrhoea reinfection alone than patients of 
physicians in a delayed control group after 9 months’ 
follow-up. Their ﬁ ndings call for a scale-up of physician 
training in HIV and STI knowledge, treatment, and risk 
reduction counselling, as an important strategy to 
prevent HIV risk and STI transmission in China as well as 
around the world.
China is among the world’s top 15 countries in terms 
of HIV incidence and total number of people living 
with HIV/AIDS and will be a crucial contributor to 
global eﬀ orts towards ending the epidemic.3 HIV/AIDS 
in China has shifted its primary transmission mode 
from infection through needle sharing and injectable 
drug use to one mainly attributable to sexual contact, 
and with staggering magnitude.4,5 The proportion 
of newly diagnosed HIV cases acquiring HIV th rough 
sexual contact increased from 60·4% in 2010 to 92·4% 
in 2014.6 The national average HIV prevalence among 
men who have sex with men increased from 1·4% in 
2005 to 8·0% in 2015.7 Control and prevention of the 
HIV epidemic as transmitted through sexual contact has 
become a top priority in China, yet it remains a great 
challenge.
The scaling up of such a physician training programme 
could encounter various hurdles. Broad dissemination 
and implementation of this type of programme calls 
for an understanding of the speciﬁ c key components 
that contribute to the positive impact seen. The 
Ai Shi Zi intervention study involved a programme 
consisting of 1-week group training and two additional 
booster sessions, incorporating didactic sessions with 
practical skills acquisition exercises. Individual-level 
interaction—ie, between physician and patient—is 
important to understand speciﬁ cs aﬀ ecting successful 
patient outcomes. In addition to the high rate of 
patient attrition reported, the scarce data collected 
regarding clinical encounters makes speciﬁ cation and 
thereby replication of eﬀ ective programme components 
diﬃ  cult.2 Feasibility is yet to be determined; the authors 
did not report costs of such a training programme, 
which was already demanding in terms of time, study 
design, and implementation. The country-wide scale-up 
of a similar programme involves a complex interplay not 
limited to institutional support and training resources.
The training programme’s reported eﬀ ectiveness in 
reducing gonorrhoea and chlamydia reinfection was 
apparent, although it might not be well generalisable 
to the case of HIV. In national sentinel surveillance of 
men who have sex with men in China, the average HIV 
prevalence saw an increase from 5·0% in 2008 to 8·0% 
in 2015, whereas the national average prevalence of 
syphilis among the same sample of MSM declined from 
13·0% to 5·3% during the same time period.7 Despite the 
existence of a few studies reporting the eﬀ ectiveness of 
physician training programmes to increase knowledge, 
improve counselling skills, reduce stigma, and reduce 
sexually transmitted infections,2,8,9 few clinical trials have 
shown similar results in reduction of HIV incidence. Such 
studies should be considered in the near future, perhaps 
extending to the Chinese men who have sex with men 
population, since this group experiences enormous 
stigma and alienation from health-care providers as well 
as the general public.
In view of the crucial role of physicians in HIV 
diagnosis and treatment, future training programmes 
should emphasise improving the rate of HIV diagnosis 
through several strategies including promoting provider 
initiation of HIV testing among patients seeking any 
medical services, or mandating HIV screening on clinical 
visits, with an opt-out option.10 Physician training 
programmes would see beneﬁ t from courses in public 
health to build knowledge and strengthen skills in the 
identiﬁ cation and prevention of HIV within the clinical 
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setting using approaches such as partner tracing, 
partner notiﬁ cation, and partner treatment. 
Recent guidelines issued by WHO encourage treating 
all HIV-infected individuals with antiretroviral therapy 
regardless of their CD4 cell level.11 This new policy will 
undoubtedly be beneﬁ cial in achieving the goal of 
90% treatment among those with known diagnoses. 
Improved training programmes emphasising this 
approach will help China and the world to achieve the 
90-90-90 targets towards ending AIDS by 2030.
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